John Kincaid

John Kincaid currently serves as the Chief Scientific Officer at Aeovian Pharmaceuticals since March 2020 and has been a Pharmaceutical Industry Consultant since January 2016. Prior experience includes roles as Scientific Co-Founder and Head of Discovery at NFlection Therapeutics from January 2017 to June 2019, as well as Vice President and Managing Director at Synterys, Inc. from December 2009 to June 2017. Additionally, John held the position of Senior Director of Drug Discovery at RENOVIS, INC. from October 2003 to September 2009, worked as a Scientist at ImClone Systems in 2001-2002, served as Associate Scientist at Amgen, Inc. from 1998 to 2001, and was a Research Associate in Medicinal Chemistry at Abbott Laboratories from 1996 to 1998.